Senti Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Senti Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q3 2024.
  • Senti Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.2M, a 65.3% increase year-over-year.
  • Senti Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.6M, a 27.6% increase year-over-year.
  • Senti Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$92.7M, a 49.4% decline from 2022.
  • Senti Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$62.1M, a 53.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$15.2M +$28.7M +65.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$13.4M +$1.83M +12.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$16.3M -$1.34M -8.94% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$18.7M -$4.89M -35.4% Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$43.9M -$29.1M -198% Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$15.2M +$6.58M +30.2% Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$15M -$3.21M -27.3% Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$13.8M +$6.22M +31.1% Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$14.7M -$3.33M -29.1% Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$21.8M -$12.8M -142% Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$11.8M -$11.8M Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$20M Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$11.4M Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$9M Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$1.18K* Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.